Source: nasdaq.com — 05-28-2025
Lonza Group has been upgraded to a ‘Strong Buy’ rating by the Zacks rating system, indicating superior earnings estimate revisions and potential market-beating returns in the near term. Unlike Wall Street analysts, Zacks maintains an equal proportion of ‘buy’ and ‘sell’ ratings for its stocks, with only the top 5% receiving a ‘Strong Buy’ and the next 15% a ‘Buy’ rating. This upgrade positions Lonza Group as a solid candidate for investors looking for promising opportunities in the biotech sector.
